REG - BSF Enterprise PLC - Publication of a Prospectus

BSF EnterpriseAnnouncement

06/03/2025 16:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250306:nRSF7035Za&default-theme=true

RNS Number : 7035Z  BSF Enterprise PLC  06 March 2025

BSF Enterprise PLC

6 March 2025

 

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR
CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY
PERSON TO SUBSCRIBE FOR, OR OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN
ANY JURISDICTION.

 

6 March 2025

BSF Enterprise PLC

Publication of Prospectus

BSF Enterprise Plc (LSE: BSFA) (OTCQB: BSFAF) (the "Company"), a leading
innovator in tissue-engineered materials, is pleased to announce that,
further to the placing announced on 4 December 2024 and 27 December 2024
("Previous Announcements"), the Company has today received approval from the
Financial Conduct Authority (the "FCA") of its prospectus (the "Prospectus")
relating to the proposed issuance (the "Share Issue") of up to 28,926,352 new
ordinary shares ("Ordinary Shares") and has published its Prospectus.

 

As described in the Previous Announcements, the Company raised approximately
£500,000 by way of placing at a price of 2.5 pence per share in December
2024. 20,000,000 Ordinary Shares were admitted to the Official List of the FCA
and to trading on the Main Market of the London Stock Exchange on 27 December
2024.

 

The Share Issue relates primarily to the warrants that were part of the
placing in December 2024 (being 2024 Placing Warrants at a price of 5 pence
per share) and part of the £2.9 million fundraise in March 2023 (being 2023
Placing Warrants, 2023 Subscription Warrants and 2023 Broker Warrants at a
price of 34 pence per share, together "2023 Fundraising Warrants", which have
not been exercised).

 

At the Company's annual general meeting on 5 March 2025, resolutions were
passed to approve the allotment of share and disapplication of pre-emption
rights in relation to the Share Issue.

An electronic copy of the Prospectus is available for inspection on the
Company's website at www.bsfenterprise.com (http://www.bsfenterprise.com) .
The Prospectus will also be available for inspection at the National Storage
Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

Applications will be made to the FCA and the London Stock Exchange for the new
Ordinary Shares in connection with the 2023 Fundraising Warrants and the 2024
Placing Warrants (upon exercise of any of them) to be admitted to the Official
List of the FCA and to trading on the Main Market of the London Stock
Exchange.  It is expected that admission of the new Ordinary Shares will
become effective within 10 business days of exercise of the warrants and that
dealings will commence at that time.

The new Ordinary Shares will, when issued, be credited as fully paid and will
rank pari passu in all respects with the existing Ordinary Shares of the
Company and will on issue be free of all claims, liens, charges, encumbrances
and equities.

Further announcements will be made in due course, as appropriate.

Terms used in this announcement shall, unless the context otherwise requires,
be as defined in the Prospectus published by the Company on 6 March 2025 in
relation to the Share Issue.

For further enquiries, please visit www.bsfenterprise.com
(http://www.bsfenterprise.com/)  or contact:

 BSF Enterprise PLC                       Via SEC Newgate below
 Geoff Baker - Executive Director

 Che Connon - CEO & Director

 Shard Capital (Broker)
 Damon Heath                              020 7186 9900

 Isabella Pierre                          0207 186 9927

 SEC Newgate (Financial Communications)
 Bob Huxford                              020 3757 6882

 Elisabeth Cowell                         BSF@secnewgate.co.uk

 George Esmond

 

ISIN of the Ordinary Shares is GB00BHNBDQ51.

SEDOL Code is BHNBDQ5.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PDIEQLFBEXLZBBV